{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:32:12Z","timestamp":1792193532231,"version":"4.4.0"},"reference-count":237,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T00:00:00Z","timestamp":1421971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T00:00:00Z","timestamp":1421971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/nri3787","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T01:30:22Z","timestamp":1421976622000},"page":"87-103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2756,"title":["Type I interferons in infectious disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Finlay","family":"McNab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Mayer-Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"O'Garra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,23]]},"reference":[{"key":"BFnri3787_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","volume":"202","author":"S Pestka","year":"2004","unstructured":"Pestka, S., Krause, C. D. & Walter, M. R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202, 8\u201332 (2004).","journal-title":"Immunol. Rev."},{"key":"BFnri3787_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn, J. R. & Wilson, C. B. Regulation of interferon-\u03b3 during innate and adaptive immune responses. Adv. Immunol. 96, 41\u2013101 (2007).","journal-title":"Adv. Immunol."},{"key":"BFnri3787_CR3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/jir.2013.0136","volume":"34","author":"TR O'Brien","year":"2014","unstructured":"O'Brien, T. R., Prokunina-Olsson, L. & Donnelly, R. P. IFN-\u03bb4: the paradoxical new member of the interferon \u03bb family. J. Interferon Cytokine Res. 34, 829\u2013838 (2014).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFnri3787_CR4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","volume":"45","author":"L Prokunina-Olsson","year":"2013","unstructured":"Prokunina-Olsson, L. et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nature Genet. 45, 164\u2013171 (2013).","journal-title":"Nature Genet."},{"key":"BFnri3787_CR5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cytogfr.2010.04.002","volume":"21","author":"K Witte","year":"2010","unstructured":"Witte, K., Witte, E., Sabat, R. & Wolk, K. IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev. 21, 237\u2013251 (2010).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnri3787_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12101","volume":"255","author":"RK Durbin","year":"2013","unstructured":"Durbin, R. K., Kotenko, S. V. & Durbin, J. E. Interferon induction and function at the mucosal surface. Immunol. Rev. 255, 25\u201339 (2013).","journal-title":"Immunol. Rev."},{"key":"BFnri3787_CR7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ni.2229","volume":"13","author":"N Yan","year":"2012","unstructured":"Yan, N. & Chen, Z. J. Intrinsic antiviral immunity. Nature Immunol. 13, 214\u2013222 (2012).","journal-title":"Nature Immunol."},{"key":"BFnri3787_CR8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.immuni.2013.05.007","volume":"38","author":"D Goubau","year":"2013","unstructured":"Goubau, D., Deddouche, S. & Reis e Sousa, C. Cytosolic sensing of viruses. Immunity 38, 855\u2013869 (2013).","journal-title":"Immunity"},{"key":"BFnri3787_CR9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.immuni.2013.05.004","volume":"38","author":"SR Paludan","year":"2013","unstructured":"Paludan, S. R. & Bowie, A. G. Immune sensing of DNA. Immunity 38, 870\u2013880 (2013).","journal-title":"Immunity"},{"key":"BFnri3787_CR10","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.ppat.0040006","volume":"4","author":"JH Leber","year":"2008","unstructured":"Leber, J. H. et al. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 4, e6 (2008).","journal-title":"PLoS Pathog."},{"key":"BFnri3787_CR11","doi-asserted-by":"crossref","first-page":"e1000500","DOI":"10.1371\/journal.ppat.1000500","volume":"5","author":"AK Pandey","year":"2009","unstructured":"Pandey, A. K. et al. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog. 5, e1000500 (2009).","journal-title":"PLoS Pathog."},{"key":"BFnri3787_CR12","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1172\/JCI39481","volume":"120","author":"T Watanabe","year":"2010","unstructured":"Watanabe, T. et al. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J. Clin. Invest. 120, 1645\u20131662 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnri3787_CR13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fimmu.2012.00328","volume":"3","author":"LO Moreira","year":"2012","unstructured":"Moreira, L. O. & Zamboni, D. S. NOD1 and NOD2 signaling in infection and inflammation. Front. Immunol. 3, 328 (2012).","journal-title":"Front. Immunol."},{"key":"BFnri3787_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.it.2005.06.009","volume":"26","author":"PN Moynagh","year":"2005","unstructured":"Moynagh, P. N. TLR signalling and activation of IRFs: revisiting old friends from the NF-\u03baB pathway. Trends Immunol. 26, 469\u2013476 (2005).","journal-title":"Trends Immunol."},{"key":"BFnri3787_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2006.08.009","volume":"25","author":"K Honda","year":"2006","unstructured":"Honda, K., Takaoka, A. & Taniguchi, T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349\u2013360 (2006).","journal-title":"Immunity"},{"key":"BFnri3787_CR16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","volume":"26","author":"T Tamura","year":"2008","unstructured":"Tamura, T., Yanai, H., Savitsky, D. & Taniguchi, T. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535\u2013584 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri3787_CR17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv, L. B. & Donlin, L. T. Regulation of type I interferon responses. Nature Rev. Immunol. 14, 36\u201349 (2014). This review is a perfect prelude to the present review and describes the molecular mechanisms of regulation of type I IFNs in more detail.","journal-title":"Nature Rev. Immunol."},{"key":"BFnri3787_CR18","first-page":"e23820","volume":"2","author":"I Rauch","year":"2013","unstructured":"Rauch, I., Muller, M. & Decker, T. The regulation of inflammation by interferons and their STATs. JAKSTAT 2, e23820 (2013).","journal-title":"JAKSTAT"},{"key":"BFnri3787_CR19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.mib.2010.05.009","volume":"13","author":"GA Versteeg","year":"2010","unstructured":"Versteeg, G. A. & Garcia-Sastre, A. Viral tricks to grid-lock the type I interferon system. Curr. Opin. Microbiol. 13, 508\u2013516 (2010).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFnri3787_CR20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coi.2010.10.021","volume":"23","author":"FW McNab","year":"2011","unstructured":"McNab, F. W., Rajsbaum, R., Stoye, J. P. & O'Garra, A. Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 23, 46\u201356 (2011).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnri3787_CR21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2013.08.014","volume":"14","author":"MS Diamond","year":"2013","unstructured":"Diamond, M. S. & Schoggins, J. W. Host restriction factor screening: let the virus do the work. Cell Host Microbe 14, 229\u2013231 (2013).","journal-title":"Cell Host Microbe"},{"key":"BFnri3787_CR22","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","volume":"264","author":"U Muller","year":"1994","unstructured":"Muller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918\u20131921 (1994).","journal-title":"Science"},{"key":"BFnri3787_CR23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1084\/jem.154.1.199","volume":"154","author":"O Haller","year":"1981","unstructured":"Haller, O., Arnheiter, H., Gresser, I. & Lindenmann, J. Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus. J. Exp. Med. 154, 199\u2013203 (1981).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR24","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.4049\/jimmunol.164.8.4220","volume":"164","author":"JE Durbin","year":"2000","unstructured":"Durbin, J. E. et al. Type I IFN modulates innate and specific antiviral immunity. J. Immunol. 164, 4220\u20134228 (2000).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR25","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1128\/JVI.72.11.8550-8558.1998","volume":"72","author":"A Garcia-Sastre","year":"1998","unstructured":"Garcia-Sastre, A. et al. The role of interferon in influenza virus tissue tropism. J. Virol. 72, 8550\u20138558 (1998).","journal-title":"J. Virol."},{"key":"BFnri3787_CR26","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1128\/JVI.01718-06","volume":"81","author":"I Koerner","year":"2007","unstructured":"Koerner, I., Kochs, G., Kalinke, U., Weiss, S. & Staeheli, P. Protective role of \u03b2 interferon in host defense against influenza A virus. J. Virol. 81, 2025\u20132030 (2007).","journal-title":"J. Virol."},{"key":"BFnri3787_CR27","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1128\/JVI.74.9.3996-4003.2000","volume":"74","author":"GE Price","year":"2000","unstructured":"Price, G. E., Gaszewska-Mastarlarz, A. & Moskophidis, D. The role of \u03b1\/\u03b2 and \u03b3 interferons in development of immunity to influenza A virus in mice. J. Virol. 74, 3996\u20134003 (2000).","journal-title":"J. Virol."},{"key":"BFnri3787_CR28","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1128\/JVI.00272-10","volume":"84","author":"M Mordstein","year":"2010","unstructured":"Mordstein, M. et al. \u03bb Interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84, 5670\u20135677 (2010).","journal-title":"J. Virol."},{"key":"BFnri3787_CR29","doi-asserted-by":"crossref","first-page":"e1000151","DOI":"10.1371\/journal.ppat.1000151","volume":"4","author":"M Mordstein","year":"2008","unstructured":"Mordstein, M. et al. Interferon-\u03bb contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4, e1000151 (2008). This study demonstrates the redundant roles of type I and type III IFNs in the anti-influenza virus response, clarifying the confusion arising from earlier literature that reported that type I IFNs cannot account for the requirement for STAT1 signalling in protection against influenza virus infection.","journal-title":"PLoS Pathog."},{"key":"BFnri3787_CR30","doi-asserted-by":"crossref","first-page":"e1003773","DOI":"10.1371\/journal.ppat.1003773","volume":"9","author":"S Crotta","year":"2013","unstructured":"Crotta, S. et al. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog. 9, e1003773 (2013). This study demonstrates the redundant roles of type I and type III IFN signalling in epithelial cells in the anti-influenza virus response, clarifying the confusion arising from earlier literature over protection against influenza virus infection.","journal-title":"PLoS Pathog."},{"key":"BFnri3787_CR31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.immuni.2012.03.016","volume":"36","author":"JL Casanova","year":"2012","unstructured":"Casanova, J. L., Holland, S. M. & Notarangelo, L. D. Inborn errors of human JAKs and STATs. Immunity 36, 515\u2013528 (2012).","journal-title":"Immunity"},{"key":"BFnri3787_CR32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-065X.2008.00698.x","volume":"226","author":"SY Zhang","year":"2008","unstructured":"Zhang, S. Y. et al. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-\u03b1\/\u03b2, IFN-\u03b3, and IFN-\u03bb in host defense. Immunol. Rev. 226, 29\u201340 (2008).","journal-title":"Immunol. Rev."},{"key":"BFnri3787_CR33","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","volume":"41","author":"V Suppiah","year":"2009","unstructured":"Suppiah, V. et al. IL28B is associated with response to chronic hepatitis C interferon-\u03b1 and ribavirin therapy. Nature Genet. 41, 1100\u20131104 (2009).","journal-title":"Nature Genet."},{"key":"BFnri3787_CR34","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","volume":"41","author":"Y Tanaka","year":"2009","unstructured":"Tanaka, Y. et al. Genome-wide association of IL28B with response to pegylated interferon-\u03b1 and ribavirin therapy for chronic hepatitis C. Nature Genet. 41, 1105\u20131109 (2009).","journal-title":"Nature Genet."},{"key":"BFnri3787_CR35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399\u2013401 (2009).","journal-title":"Nature"},{"key":"BFnri3787_CR36","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas, D. L. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798\u2013801 (2009).","journal-title":"Nature"},{"key":"BFnri3787_CR37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nature13554","volume":"511","author":"NG Sandler","year":"2014","unstructured":"Sandler, N. G. et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511, 601\u2013605 (2014).","journal-title":"Nature"},{"key":"BFnri3787_CR38","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10921","volume":"484","author":"AR Everitt","year":"2012","unstructured":"Everitt, A. R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519\u2013523 (2012). This study provided the first evidence of host genetics ( IFITM3 ) contributing to susceptibility to influenza virus infection in humans.","journal-title":"Nature"},{"key":"BFnri3787_CR39","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/ncomms2433","volume":"4","author":"YH Zhang","year":"2013","unstructured":"Zhang, Y. H. et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nature Commun. 4, 1418 (2013). This is a follow-up study to reference 38, showing that  IFITM3  variants that contribute to the severity of influenza virus infection are predominant in the Chinese population.","journal-title":"Nature Commun."},{"key":"BFnri3787_CR40","first-page":"4518","volume":"8","author":"P Staeheli","year":"1988","unstructured":"Staeheli, P., Grob, R., Meier, E., Sutcliffe, J. G. & Haller, O. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 8, 4518\u20134523 (1988).","journal-title":"Mol. Cell. Biol."},{"key":"BFnri3787_CR41","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1073\/pnas.80.7.1910","volume":"80","author":"MA Horisberger","year":"1983","unstructured":"Horisberger, M. A., Staeheli, P. & Haller, O. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc. Natl Acad. Sci. USA 80, 1910\u20131914 (1983).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3787_CR42","doi-asserted-by":"crossref","first-page":"e33180","DOI":"10.1371\/journal.pone.0033180","volume":"7","author":"P Horby","year":"2012","unstructured":"Horby, P., Nguyen, N. Y., Dunstan, S. J. & Baillie, J. K. The role of host genetics in susceptibility to influenza: a systematic review. PLoS ONE 7, e33180 (2012).","journal-title":"PLoS ONE"},{"key":"BFnri3787_CR43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1365-2567.2003.01702.x","volume":"110","author":"M Dauer","year":"2003","unstructured":"Dauer, M. et al. Interferon-\u03b1 disables dendritic cell precursors: dendritic cells derived from interferon-\u03b1-treated monocytes are defective in maturation and T-cell stimulation. Immunology 110, 38\u201347 (2003).","journal-title":"Immunology"},{"key":"BFnri3787_CR44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.20021924","volume":"198","author":"C Lapenta","year":"2003","unstructured":"Lapenta, C. et al. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-\u03b1. J. Exp. Med. 198, 361\u2013367 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR45","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","volume":"191","author":"SM Santini","year":"2000","unstructured":"Santini, S. M. et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191, 1777\u20131788 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR46","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.4049\/jimmunol.170.10.5195","volume":"170","author":"L Santodonato","year":"2003","unstructured":"Santodonato, L. et al. Monocyte-derived dendritic cells generated after a short-term culture with IFN-\u03b1 and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response. J. Immunol. 170, 5195\u20135202 (2003).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.immuni.2005.01.005","volume":"22","author":"B Hahm","year":"2005","unstructured":"Hahm, B., Trifilo, M. J., Zuniga, E. I. & Oldstone, M. B. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22, 247\u2013257 (2005).","journal-title":"Immunity"},{"key":"BFnri3787_CR48","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.4049\/jimmunol.166.5.2961","volume":"166","author":"T Ito","year":"2001","unstructured":"Ito, T. et al. Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166, 2961\u20132969 (2001).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR49","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood.V99.9.3263","volume":"99","author":"M Montoya","year":"2002","unstructured":"Montoya, M. et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99, 3263\u20133271 (2002).","journal-title":"Blood"},{"key":"BFnri3787_CR50","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni978","volume":"4","author":"A Le Bon","year":"2003","unstructured":"Le Bon, A. et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nature Immunol. 4, 1009\u20131015 (2003).","journal-title":"Nature Immunol."},{"key":"BFnri3787_CR51","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.4049\/jimmunol.176.8.4682","volume":"176","author":"A Le Bon","year":"2006","unstructured":"Le Bon, A. et al. Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J. Immunol. 176, 4682\u20134689 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR52","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1182\/blood-2011-06-363564","volume":"119","author":"F Spadaro","year":"2012","unstructured":"Spadaro, F. et al. IFN-\u03b1 enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing. Blood 119, 1407\u20131417 (2012).","journal-title":"Blood"},{"key":"BFnri3787_CR53","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V98.10.3022","volume":"98","author":"S Parlato","year":"2001","unstructured":"Parlato, S. et al. Expression of CCR-7, MIP-3\u03b2, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. Blood 98, 3022\u20133029 (2001).","journal-title":"Blood"},{"key":"BFnri3787_CR54","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1002\/eji.201040523","volume":"40","author":"A Rouzaut","year":"2010","unstructured":"Rouzaut, A. et al. Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN-\u03b1. Eur. J. Immunol. 40, 3054\u20133063 (2010).","journal-title":"Eur. J. Immunol."},{"key":"BFnri3787_CR55","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.20041964","volume":"201","author":"G Gautier","year":"2005","unstructured":"Gautier, G. et al. A type I interferon autocrine\u2013paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 201, 1435\u20131446 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR56","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1073\/pnas.94.2.634","volume":"94","author":"LP Cousens","year":"1997","unstructured":"Cousens, L. P., Orange, J. S., Su, H. C. & Biron, C. A. Interferon-\u03b1\/\u03b2 inhibition of interleukin 12 and interferon-\u03b3 production in vitro and endogenously during viral infection. Proc. Natl Acad. Sci. USA 94, 634\u2013639 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3787_CR57","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.20011672","volume":"195","author":"M Dalod","year":"2002","unstructured":"Dalod, M. et al. Interferon \u03b1\/\u03b2 and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195, 517\u2013528 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR58","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4049\/jimmunol.152.3.1253","volume":"152","author":"JS Orange","year":"1994","unstructured":"Orange, J. S., Wolf, S. F. & Biron, C. A. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152, 1253\u20131264 (1994).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR59","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.181.3.901","volume":"181","author":"JS Orange","year":"1995","unstructured":"Orange, J. S. et al. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J. Exp. Med. 181, 901\u2013914 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR60","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.4049\/jimmunol.176.4.2074","volume":"176","author":"A Le Bon","year":"2006","unstructured":"Le Bon, A. et al. Enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 176, 2074\u20132078 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR61","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.4049\/jimmunol.176.6.3315","volume":"176","author":"C Havenar-Daughton","year":"2006","unstructured":"Havenar-Daughton, C., Kolumam, G. A. & Murali-Krishna, K. The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 176, 3315\u20133319 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR62","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.178.5.1655","volume":"178","author":"V Brinkmann","year":"1993","unstructured":"Brinkmann, V., Geiger, T., Alkan, S. & Heusser, C. H. Interferon \u03b1 increases the frequency of interferon \u03b3-producing human CD4+ T cells. J. Exp. Med. 178, 1655\u20131663 (1993).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR63","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1128\/JVI.07147-11","volume":"86","author":"MJ Hofer","year":"2012","unstructured":"Hofer, M. J. et al. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus. J. Virol. 86, 6932\u20136946 (2012).","journal-title":"J. Virol."},{"key":"BFnri3787_CR64","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1128\/JVI.00396-11","volume":"85","author":"HM Lazear","year":"2011","unstructured":"Lazear, H. M., Pinto, A. K., Vogt, M. R., Gale, M. Jr & Diamond, M. S. \u03b2-Interferon controls West Nile virus infection and pathogenesis in mice. J. Virol. 85, 7186\u20137194 (2011).","journal-title":"J. Virol."},{"key":"BFnri3787_CR65","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature04606","volume":"440","author":"LR Shiow","year":"2006","unstructured":"Shiow, L. R. et al. CD69 acts downstream of interferon-\u03b1\/\u03b2 to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440, 540\u2013544 (2006).","journal-title":"Nature"},{"key":"BFnri3787_CR66","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/37648","volume":"390","author":"EF Petricoin","year":"1997","unstructured":"Petricoin, E. F. et al. Antiproliferative action of interferon-\u03b1 requires components of T-cell-receptor signalling. Nature 390, 629\u2013632 (1997).","journal-title":"Nature"},{"key":"BFnri3787_CR67","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1006\/cyto.1998.0484","volume":"11","author":"A Kaser","year":"1999","unstructured":"Kaser, A., Nagata, S. & Tilg, H. Interferon \u03b1 augments activation-induced T cell death by upregulation of Fas (CD95\/APO-1) and Fas ligand expression. Cytokine 11, 736\u2013743 (1999).","journal-title":"Cytokine"},{"key":"BFnri3787_CR68","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1128\/JVI.02516-10","volume":"85","author":"HD Marshall","year":"2011","unstructured":"Marshall, H. D., Urban, S. L. & Welsh, R. M. Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon. J. Virol. 85, 5929\u20135939 (2011).","journal-title":"J. Virol."},{"key":"BFnri3787_CR69","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1073\/pnas.93.15.7673","volume":"93","author":"JF Bromberg","year":"1996","unstructured":"Bromberg, J. F., Horvath, C. M., Wen, Z., Schreiber, R. D. & Darnell, J. E. Jr. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon \u03b1 and interferon \u03b3. Proc. Natl. Acad. Sci. USA 93, 7673\u20137678 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnri3787_CR70","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.4049\/jimmunol.164.3.1286","volume":"164","author":"CK Lee","year":"2000","unstructured":"Lee, C. K., Smith, E., Gimeno, R., Gertner, R. & Levy, D. E. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-\u03b3. J. Immunol. 164, 1286\u20131292 (2000).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR71","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4049\/jimmunol.174.2.609","volume":"174","author":"Y Tanabe","year":"2005","unstructured":"Tanabe, Y. et al. Role of STAT1, STAT3, and STAT5 in IFN-\u03b1\/\u03b2 responses in T lymphocytes. J. Immunol. 174, 609\u2013613 (2005).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR72","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.189.3.521","volume":"189","author":"P Marrack","year":"1999","unstructured":"Marrack, P., Kappler, J. & Mitchell, T. Type I interferons keep activated T cells alive. J. Exp. Med. 189, 521\u2013530 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR73","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.176.8.4525","volume":"176","author":"P Aichele","year":"2006","unstructured":"Aichele, P. et al. CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J. Immunol. 176, 4525\u20134529 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR74","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20050821","volume":"202","author":"GA Kolumam","year":"2005","unstructured":"Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. & Murali-Krishna, K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202, 637\u2013650 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR75","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.174.8.4465","volume":"174","author":"JM Curtsinger","year":"2005","unstructured":"Curtsinger, J. M., Valenzuela, J. O., Agarwal, P., Lins, D. & Mescher, M. F. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174, 4465\u20134469 (2005).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR76","doi-asserted-by":"crossref","first-page":"e40865","DOI":"10.1371\/journal.pone.0040865","volume":"7","author":"SJ Keppler","year":"2012","unstructured":"Keppler, S. J., Rosenits, K., Koegl, T., Vucikuja, S. & Aichele, P. Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses. PLoS ONE 7, e40865 (2012).","journal-title":"PLoS ONE"},{"key":"BFnri3787_CR77","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1128\/MCB.25.13.5456-5465.2005","volume":"25","author":"R Gimeno","year":"2005","unstructured":"Gimeno, R., Lee, C. K., Schindler, C. & Levy, D. E. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by \u03b1\/\u03b2 interferon in T lymphocytes. Mol. Cell. Biol. 25, 5456\u20135465 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"BFnri3787_CR78","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1182\/blood-2005-07-2834","volume":"107","author":"MP Gil","year":"2006","unstructured":"Gil, M. P., Salomon, R., Louten, J. & Biron, C. A. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood 107, 987\u2013993 (2006).","journal-title":"Blood"},{"key":"BFnri3787_CR79","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.4049\/jimmunol.0900592","volume":"183","author":"P Agarwal","year":"2009","unstructured":"Agarwal, P. et al. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J. Immunol. 183, 1695\u20131704 (2009).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR80","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4049\/jimmunol.1001140","volume":"185","author":"HD Marshall","year":"2010","unstructured":"Marshall, H. D., Prince, A. L., Berg, L. J. & Welsh, R. M. IFN-\u03b1\/\u03b2 and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions. J. Immunol. 185, 1419\u20131428 (2010).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR81","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1084\/jem.189.8.1315","volume":"189","author":"LP Cousens","year":"1999","unstructured":"Cousens, L. P. et al. Two roads diverged: interferon \u03b1\/\u03b2- and interleukin 12-mediated pathways in promoting T cell interferon \u03b3 responses during viral infection. J. Exp. Med. 189, 1315\u20131328 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR82","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1126\/science.1074900","volume":"297","author":"KB Nguyen","year":"2002","unstructured":"Nguyen, K. B. et al. Critical role for STAT4 activation by type 1 interferons in the interferon-\u03b3 response to viral infection. Science 297, 2063\u20132066 (2002).","journal-title":"Science"},{"key":"BFnri3787_CR83","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/76940","volume":"1","author":"KB Nguyen","year":"2000","unstructured":"Nguyen, K. B. et al. Interferon \u03b1\/\u03b2-mediated inhibition and promotion of interferon \u03b3: STAT1 resolves a paradox. Nature Immunol. 1, 70\u201376 (2000).","journal-title":"Nature Immunol."},{"key":"BFnri3787_CR84","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.177.3.1746","volume":"177","author":"LJ Thompson","year":"2006","unstructured":"Thompson, L. J., Kolumam, G. A., Thomas, S. & Murali-Krishna, K. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J. Immunol. 177, 1746\u20131754 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR85","doi-asserted-by":"crossref","first-page":"e1002407","DOI":"10.1371\/journal.ppat.1002407","volume":"7","author":"AK Pinto","year":"2011","unstructured":"Pinto, A. K. et al. A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection. PLoS Pathog. 7, e1002407 (2011).","journal-title":"PLoS Pathog."},{"key":"BFnri3787_CR86","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1182\/blood-2008-11-188458","volume":"113","author":"HJ Ramos","year":"2009","unstructured":"Ramos, H. J. et al. Reciprocal responsiveness to interleukin-12 and interferon-\u03b1 specifies human CD8+ effector versus central memory T-cell fates. Blood 113, 5516\u20135525 (2009).","journal-title":"Blood"},{"key":"BFnri3787_CR87","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.immuni.2010.06.016","volume":"33","author":"JE Kohlmeier","year":"2010","unstructured":"Kohlmeier, J. E., Cookenham, T., Roberts, A. D., Miller, S. C. & Woodland, D. L. Type I interferons regulate cytolytic activity of memory CD8+ T cells in the lung airways during respiratory virus challenge. Immunity 33, 96\u2013105 (2010).","journal-title":"Immunity"},{"key":"BFnri3787_CR88","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.cell.2012.08.015","volume":"150","author":"JH Sung","year":"2012","unstructured":"Sung, J. H. et al. Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell 150, 1249\u20131263 (2012).","journal-title":"Cell"},{"key":"BFnri3787_CR89","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.immuni.2012.05.029","volume":"37","author":"SM Soudja","year":"2012","unstructured":"Soudja, S. M., Ruiz, A. L., Marie, J. C. & Lauvau, G. Inflammatory monocytes activate memory CD8+ T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 37, 549\u2013562 (2012).","journal-title":"Immunity"},{"key":"BFnri3787_CR90","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.immuni.2014.05.003","volume":"40","author":"J Crouse","year":"2014","unstructured":"Crouse, J. et al. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity 40, 961\u2013973 (2014).","journal-title":"Immunity"},{"key":"BFnri3787_CR91","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2014.05.004","volume":"40","author":"HC Xu","year":"2014","unstructured":"Xu, H. C. et al. Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. Immunity 40, 949\u2013960 (2014).","journal-title":"Immunity"},{"key":"BFnri3787_CR92","doi-asserted-by":"crossref","first-page":"e51858","DOI":"10.1371\/journal.pone.0051858","volume":"7","author":"I Hwang","year":"2012","unstructured":"Hwang, I. et al. Activation mechanisms of natural killer cells during influenza virus infection. PLoS ONE 7, e51858 (2012).","journal-title":"PLoS ONE"},{"key":"BFnri3787_CR93","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.4049\/jimmunol.180.3.1592","volume":"180","author":"J Martinez","year":"2008","unstructured":"Martinez, J., Huang, X. & Yang, Y. Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J. Immunol. 180, 1592\u20131597 (2008).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR94","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.4049\/jimmunol.169.8.4279","volume":"169","author":"KB Nguyen","year":"2002","unstructured":"Nguyen, K. B. et al. Coordinated and distinct roles for IFN-\u03b1\/\u03b2, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169, 4279\u20134287 (2002).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR95","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2007.03.006","volume":"26","author":"M Lucas","year":"2007","unstructured":"Lucas, M., Schachterle, W., Oberle, K., Aichele, P. & Diefenbach, A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26, 503\u2013517 (2007).","journal-title":"Immunity"},{"key":"BFnri3787_CR96","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.4049\/jimmunol.0901872","volume":"183","author":"JC Sun","year":"2009","unstructured":"Sun, J. C., Ma, A. & Lanier, L. L. IL-15-independent NK cell response to mouse cytomegalovirus infection. J. Immunol. 183, 2911\u20132914 (2009).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR97","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.chom.2012.09.002","volume":"12","author":"T Baranek","year":"2012","unstructured":"Baranek, T. et al. Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. Cell Host Microbe 12, 571\u2013584 (2012).","journal-title":"Cell Host Microbe"},{"key":"BFnri3787_CR98","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1084\/jem.20070401","volume":"204","author":"T Miyagi","year":"2007","unstructured":"Miyagi, T. et al. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J. Exp. Med. 204, 2383\u20132396 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR99","doi-asserted-by":"crossref","first-page":"e00169-11","DOI":"10.1128\/mBio.00169-11","volume":"2","author":"EA Mack","year":"2011","unstructured":"Mack, E. A., Kallal, L. E., Demers, D. A. & Biron, C. A. Type 1 interferon induction of natural killer cell \u03b3 interferon production for defense during lymphocytic choriomeningitis virus infection. MBio 2, e00169-11 (2011).","journal-title":"MBio"},{"key":"BFnri3787_CR100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/1074-7613(95)90176-0","volume":"3","author":"J Wang","year":"1995","unstructured":"Wang, J., Lin, Q., Langston, H. & Cooper, M. D. Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells. Immunity 3, 475\u2013484 (1995).","journal-title":"Immunity"},{"key":"BFnri3787_CR101","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.187.1.79","volume":"187","author":"Q Lin","year":"1998","unstructured":"Lin, Q., Dong, C. & Cooper, M. D. Impairment of T and B cell development by treatment with a type I interferon. J. Exp. Med. 187, 79\u201387 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR102","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1089\/107999001753124453","volume":"21","author":"E Bosio","year":"2001","unstructured":"Bosio, E., Cluning, C. L. & Beilharz, M. W. Low-dose orally administered type I interferon reduces splenic B cell numbers in mice. J. Interferon Cytokine Res. 21, 721\u2013728 (2001).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFnri3787_CR103","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1074-7613(01)00126-1","volume":"14","author":"A Le Bon","year":"2001","unstructured":"Le Bon, A. et al. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14, 461\u2013470 (2001).","journal-title":"Immunity"},{"key":"BFnri3787_CR104","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.20092695","volume":"207","author":"CL Swanson","year":"2010","unstructured":"Swanson, C. L. et al. Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J. Exp. Med. 207, 1485\u20131500 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR105","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.4049\/jimmunol.176.7.4343","volume":"176","author":"ES Coro","year":"2006","unstructured":"Coro, E. S., Chang, W. L. & Baumgarth, N. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J. Immunol. 176, 4343\u20134351 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR106","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4049\/jimmunol.178.3.1457","volume":"178","author":"WL Chang","year":"2007","unstructured":"Chang, W. L. et al. Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals. J. Immunol. 178, 1457\u20131467 (2007).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR107","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.4049\/jimmunol.0803783","volume":"183","author":"FC Rau","year":"2009","unstructured":"Rau, F. C., Dieter, J., Luo, Z., Priest, S. O. & Baumgarth, N. B7-1\/2 (CD80\/CD86) direct signaling to B cells enhances IgG secretion. J. Immunol. 183, 7661\u20137671 (2009).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR108","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.4049\/jimmunol.178.4.2182","volume":"178","author":"AK Heer","year":"2007","unstructured":"Heer, A. K. et al. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J. Immunol. 178, 2182\u20132191 (2007).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR109","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/eji.200635993","volume":"36","author":"K Fink","year":"2006","unstructured":"Fink, K. et al. Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses. Eur. J. Immunol. 36, 2094\u20132105 (2006).","journal-title":"Eur. J. Immunol."},{"key":"BFnri3787_CR110","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.4049\/jimmunol.178.9.5839","volume":"178","author":"P Bach","year":"2007","unstructured":"Bach, P. et al. Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies. J. Immunol. 178, 5839\u20135847 (2007).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR111","doi-asserted-by":"crossref","first-page":"10964","DOI":"10.1128\/JVI.01646-08","volume":"82","author":"WE Purtha","year":"2008","unstructured":"Purtha, W. E., Chachu, K. A., Virgin, H. W. & Diamond, M. S. Early B-cell activation after West Nile virus infection requires \u03b1\/\u03b2 interferon but not antigen receptor signaling. J. Virol. 82, 10964\u201310974 (2008).","journal-title":"J. Virol."},{"key":"BFnri3787_CR112","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2012.01.013","volume":"36","author":"EA Moseman","year":"2012","unstructured":"Moseman, E. A. et al. B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity. Immunity 36, 415\u2013426 (2012).","journal-title":"Immunity"},{"key":"BFnri3787_CR113","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1074-7613(01)00154-6","volume":"14","author":"CA Biron","year":"2001","unstructured":"Biron, C. A. Interferons \u03b1 and \u03b2 as immune regulators \u2014 a new look. Immunity 14, 661\u2013664 (2001).","journal-title":"Immunity"},{"key":"BFnri3787_CR114","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1038\/ncomms4864","volume":"5","author":"S Davidson","year":"2014","unstructured":"Davidson, S., Crotta, S., McCabe, T. M. & Wack, A. Pathogenic potential of interferon \u03b1\u03b2 in acute influenza infection. Nature Commun. 5, 3864 (2014). This seminal publication shows that, in contrast to the dogma, type I IFNs can cause morbidity and mortality, as opposed to protection, during influenza virus infection.","journal-title":"Nature Commun."},{"key":"BFnri3787_CR115","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm.1871","volume":"14","author":"JN Mandl","year":"2008","unstructured":"Mandl, J. N. et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nature Med. 14, 1077\u20131087 (2008).","journal-title":"Nature Med."},{"key":"BFnri3787_CR116","first-page":"3544","volume":"119","author":"B Jacquelin","year":"2009","unstructured":"Jacquelin, B. et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Invest. 119, 3544\u20133555 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnri3787_CR117","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1172\/JCI45235","volume":"121","author":"M Rotger","year":"2011","unstructured":"Rotger, M. et al. Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J. Clin. Invest. 121, 2391\u20132400 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnri3787_CR118","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1128\/JVI.75.13.5965-5976.2001","volume":"75","author":"JM McNally","year":"2001","unstructured":"McNally, J. M. et al. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol. 75, 5965\u20135976 (2001).","journal-title":"J. Virol."},{"key":"BFnri3787_CR119","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/JVI.80.10.5032-5040.2006","volume":"80","author":"B Chi","year":"2006","unstructured":"Chi, B. et al. \u03b1 and \u03bb interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J. Virol. 80, 5032\u20135040 (2006).","journal-title":"J. Virol."},{"key":"BFnri3787_CR120","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1182\/blood-2012-05-428672","volume":"120","author":"MP Gil","year":"2012","unstructured":"Gil, M. P. et al. Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function. Blood 120, 3718\u20133728 (2012).","journal-title":"Blood"},{"key":"BFnri3787_CR121","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1073\/pnas.0600363103","volume":"103","author":"JP Herbeuval","year":"2006","unstructured":"Herbeuval, J. P. et al. Differential expression of IFN-\u03b1 and TRAIL\/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients. Proc. Natl Acad. Sci. USA 103, 7000\u20137005 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3787_CR122","doi-asserted-by":"crossref","first-page":"17453","DOI":"10.1073\/pnas.0707244104","volume":"104","author":"AW Hardy","year":"2007","unstructured":"Hardy, A. W., Graham, D. R., Shearer, G. M. & Herbeuval, J. P. HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-\u03b1. Proc. Natl Acad. Sci. USA 104, 17453\u201317458 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3787_CR123","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2005-03-1243","volume":"106","author":"JP Herbeuval","year":"2005","unstructured":"Herbeuval, J. P. et al. CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL\/DR5-mediated apoptosis. Blood 106, 3524\u20133531 (2005).","journal-title":"Blood"},{"key":"BFnri3787_CR124","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1172\/JCI59211","volume":"121","author":"J van Grevenynghe","year":"2011","unstructured":"van Grevenynghe, J. et al. Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosis. J. Clin. Invest. 121, 3877\u20133888 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnri3787_CR125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhep.2005.07.020","volume":"44","author":"C Liedtke","year":"2006","unstructured":"Liedtke, C., Groger, N., Manns, M. P. & Trautwein, C. Interferon-\u03b1 enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells. J. Hepatol. 44, 342\u2013349 (2006).","journal-title":"J. Hepatol."},{"key":"BFnri3787_CR126","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/sj.onc.1206139","volume":"22","author":"M Shigeno","year":"2003","unstructured":"Shigeno, M. et al. Interferon-\u03b1 sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-\u03baB inactivation. Oncogene 22, 1653\u20131662 (2003).","journal-title":"Oncogene"},{"key":"BFnri3787_CR127","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1038\/sj.onc.1204895","volume":"20","author":"NL Toomey","year":"2001","unstructured":"Toomey, N. L. et al. Induction of a TRAIL-mediated suicide program by interferon \u03b1 in primary effusion lymphoma. Oncogene 20, 7029\u20137040 (2001).","journal-title":"Oncogene"},{"key":"BFnri3787_CR128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","volume":"340","author":"JR Teijaro","year":"2013","unstructured":"Teijaro, J. R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207\u2013211 (2013).","journal-title":"Science"},{"key":"BFnri3787_CR129","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","volume":"340","author":"EB Wilson","year":"2013","unstructured":"Wilson, E. B. et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340, 202\u2013207 (2013). References 128 and 129 were the first to show that type I IFNs contribute to pathogenesis by inducing suppressive mechanisms in chronic LCMV infection.","journal-title":"Science"},{"key":"BFnri3787_CR130","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1084\/jem.20080201","volume":"205","author":"S Herold","year":"2008","unstructured":"Herold, S. et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J. Exp. Med. 205, 3065\u20133077 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR131","doi-asserted-by":"crossref","first-page":"e1003188","DOI":"10.1371\/journal.ppat.1003188","volume":"9","author":"K Hogner","year":"2013","unstructured":"Hogner, K. et al. Macrophage-expressed IFN-\u03b2 contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog. 9, e1003188 (2013).","journal-title":"PLoS Pathog."},{"key":"BFnri3787_CR132","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4049\/jimmunol.176.1.248","volume":"176","author":"L Chaperot","year":"2006","unstructured":"Chaperot, L. et al. Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J. Immunol. 176, 248\u2013255 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR133","doi-asserted-by":"crossref","first-page":"e55321","DOI":"10.1371\/journal.pone.0055321","volume":"8","author":"D Fujikura","year":"2013","unstructured":"Fujikura, D. et al. Type-I interferon is critical for FasL expression on lung cells to determine the severity of influenza. PLoS ONE 8, e55321 (2013).","journal-title":"PLoS ONE"},{"key":"BFnri3787_CR134","doi-asserted-by":"crossref","first-page":"12916","DOI":"10.1128\/JVI.02423-13","volume":"87","author":"B McNally","year":"2013","unstructured":"McNally, B., Ye, F., Willette, M. & Flano, E. Local blockade of epithelial PDL-1 in the airways enhances T cell function and viral clearance during influenza virus infection. J. Virol. 87, 12916\u201312924 (2013).","journal-title":"J. Virol."},{"key":"BFnri3787_CR135","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.4049\/jimmunol.1002241","volume":"187","author":"EL Brincks","year":"2011","unstructured":"Brincks, E. L. et al. The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL. J. Immunol. 187, 4581\u20134588 (2011).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR136","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri3210","volume":"12","author":"JD MacMicking","year":"2012","unstructured":"MacMicking, J. D. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nature Rev. Immunol. 12, 367\u2013382 (2012).","journal-title":"Nature Rev. Immunol."},{"key":"BFnri3787_CR137","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/iai.3.6.825-832.1971","volume":"3","author":"J Kazar","year":"1971","unstructured":"Kazar, J., Gillmore, J. D. & Gordon, F. B. Effect of interferon and interferon inducers on infections with a nonviral intracellular microorganism, Chlamydia trachomatis. Infect. Immun. 3, 825\u2013832 (1971).","journal-title":"Infect. Immun."},{"key":"BFnri3787_CR138","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/iai.47.3.719-722.1985","volume":"47","author":"LM de la Maza","year":"1985","unstructured":"de la Maza, L. M., Peterson, E. M., Goebel, J. M., Fennie, C. W. & Czarniecki, C. W. Interferon-induced inhibition of Chlamydia trachomatis: dissociation from antiviral and antiproliferative effects. Infect. Immun. 47, 719\u2013722 (1985).","journal-title":"Infect. Immun."},{"key":"BFnri3787_CR139","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2220\/biomedres.26.179","volume":"26","author":"T Ishihara","year":"2005","unstructured":"Ishihara, T. et al. Inhibition of Chlamydia trachomatis growth by human interferon-\u03b1: mechanisms and synergistic effect with interferon-\u03b3 and tumor necrosis factor-\u03b1. Biomed. Res. 26, 179\u2013185 (2005).","journal-title":"Biomed. Res."},{"key":"BFnri3787_CR140","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.4049\/jimmunol.167.11.6453","volume":"167","author":"AG Rothfuchs","year":"2001","unstructured":"Rothfuchs, A. G. et al. IFN-\u03b1\/\u03b2-dependent, IFN-\u03b3 secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J. Immunol. 167, 6453\u20136461 (2001).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR141","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.4049\/jimmunol.176.11.6982","volume":"176","author":"AG Rothfuchs","year":"2006","unstructured":"Rothfuchs, A. G. et al. STAT1 regulates IFN-\u03b1\u03b2- and IFN-\u03b3-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells. J. Immunol. 176, 6982\u20136990 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR142","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.4049\/jimmunol.181.3.2092","volume":"181","author":"H Qiu","year":"2008","unstructured":"Qiu, H. et al. Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages. J. Immunol. 181, 2092\u20132102 (2008).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR143","doi-asserted-by":"crossref","first-page":"36173","DOI":"10.1074\/jbc.M604638200","volume":"281","author":"B Opitz","year":"2006","unstructured":"Opitz, B. et al. Legionella pneumophila induces IFN\u03b2 in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J. Biol. Chem. 281, 36173\u201336179 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnri3787_CR144","doi-asserted-by":"crossref","first-page":"30058","DOI":"10.1074\/jbc.M109.018283","volume":"284","author":"CR Plumlee","year":"2009","unstructured":"Plumlee, C. R. et al. Interferons direct an effective innate response to Legionella pneumophila infection. J. Biol. Chem. 284, 30058\u201330066 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnri3787_CR145","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4049\/jimmunol.173.2.1266","volume":"173","author":"G Schiavoni","year":"2004","unstructured":"Schiavoni, G. et al. Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-\u03b3-independent pathway. J. Immunol. 173, 1266\u20131275 (2004).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR146","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1128\/IAI.72.3.1291-1297.2004","volume":"72","author":"JA Gold","year":"2004","unstructured":"Gold, J. A. et al. Exogenous \u03b3 and \u03b1\/\u03b2 interferon rescues human macrophages from cell death induced by Bacillus anthracis. Infect. Immun. 72, 1291\u20131297 (2004).","journal-title":"Infect. Immun."},{"key":"BFnri3787_CR147","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/iai.45.1.62-66.1984","volume":"45","author":"G Bukholm","year":"1984","unstructured":"Bukholm, G., Berdal, B. P., Haug, C. & Degre, M. Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice. Infect. Immun. 45, 62\u201366 (1984).","journal-title":"Infect. Immun."},{"key":"BFnri3787_CR148","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/iai.52.3.828-833.1986","volume":"52","author":"DW Niesel","year":"1986","unstructured":"Niesel, D. W., Hess, C. B., Cho, Y. J., Klimpel, K. D. & Klimpel, G. R. Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp. Infect. Immun. 52, 828\u2013833 (1986).","journal-title":"Infect. Immun."},{"key":"BFnri3787_CR149","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.4049\/jimmunol.178.5.3126","volume":"178","author":"G Mancuso","year":"2007","unstructured":"Mancuso, G. et al. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J. Immunol. 178, 3126\u20133133 (2007).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR150","doi-asserted-by":"crossref","first-page":"e00016-11","DOI":"10.1128\/mBio.00016-11","volume":"2","author":"D Parker","year":"2011","unstructured":"Parker, D. et al. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. MBio 2, e00016-11 (2011).","journal-title":"MBio"},{"key":"BFnri3787_CR151","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0882-4010(86)90071-9","volume":"1","author":"DA Weigent","year":"1986","unstructured":"Weigent, D. A., Huff, T. L., Peterson, J. W., Stanton, G. J. & Baron, S. Role of interferon in streptococcal infection in the mouse. Microb. Pathog. 1, 399\u2013407 (1986).","journal-title":"Microb. Pathog."},{"key":"BFnri3787_CR152","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.20091959","volume":"207","author":"KM Kelly-Scumpia","year":"2010","unstructured":"Kelly-Scumpia, K. M. et al. Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10. J. Exp. Med. 207, 319\u2013326 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR153","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.4049\/jimmunol.177.8.5623","volume":"177","author":"H Weighardt","year":"2006","unstructured":"Weighardt, H. et al. Type I IFN modulates host defense and late hyperinflammation in septic peritonitis. J. Immunol. 177, 5623\u20135630 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR154","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.4049\/jimmunol.169.4.1665","volume":"169","author":"MA Freudenberg","year":"2002","unstructured":"Freudenberg, M. A. et al. A murine, IL-12-independent pathway of IFN-\u03b3 induction by Gram-negative bacteria based on STAT4 activation by type I IFN and IL-18 signaling. J. Immunol. 169, 1665\u20131668 (2002).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.20040976","volume":"200","author":"V Auerbuch","year":"2004","unstructured":"Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O'Riordan, M. & Portnoy, D. A. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200, 527\u2013533 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR156","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1084\/jem.20040769","volume":"200","author":"JA Carrero","year":"2004","unstructured":"Carrero, J. A., Calderon, B. & Unanue, E. R. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 200, 535\u2013540 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR157","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1084\/jem.20040712","volume":"200","author":"RM O'Connell","year":"2004","unstructured":"O'Connell, R. M. et al. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J. Exp. Med. 200, 437\u2013445 (2004). References 155\u2013157 were the first publications demonstrating an adverse effect of type I IFNs in intracellular infection with the bacterium  L. monocytogenes.","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR158","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.20060045","volume":"203","author":"JA Carrero","year":"2006","unstructured":"Carrero, J. A., Calderon, B. & Unanue, E. R. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J. Exp. Med. 203, 933\u2013940 (2006).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR159","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.4049\/jimmunol.169.11.6522","volume":"169","author":"S Stockinger","year":"2002","unstructured":"Stockinger, S. et al. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J. Immunol. 169, 6522\u20136529 (2002).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR160","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.4049\/jimmunol.180.6.4116","volume":"180","author":"H Zwaferink","year":"2008","unstructured":"Zwaferink, H., Stockinger, S., Hazemi, P., Lemmens-Gruber, R. & Decker, T. IFN-\u03b2 increases listeriolysin O-induced membrane permeabilization and death of macrophages. J. Immunol. 180, 4116\u20134123 (2008).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR161","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/IAI.01251-07","volume":"76","author":"H Zwaferink","year":"2008","unstructured":"Zwaferink, H., Stockinger, S., Reipert, S. & Decker, T. Stimulation of inducible nitric oxide synthase expression by \u03b2 interferon increases necrotic death of macrophages upon Listeria monocytogenes infection. Infect. Immun. 76, 1649\u20131656 (2008).","journal-title":"Infect. Immun."},{"key":"BFnri3787_CR162","doi-asserted-by":"crossref","first-page":"e15567","DOI":"10.1371\/journal.pone.0015567","volume":"5","author":"P Dresing","year":"2010","unstructured":"Dresing, P., Borkens, S., Kocur, M., Kropp, S. & Scheu, S. A fluorescence reporter model defines \u201cTip-DCs\u201d as the cellular source of interferon \u03b2 in murine listeriosis. PLoS ONE 5, e15567 (2010).","journal-title":"PLoS ONE"},{"key":"BFnri3787_CR163","doi-asserted-by":"crossref","first-page":"e1000355","DOI":"10.1371\/journal.ppat.1000355","volume":"5","author":"S Stockinger","year":"2009","unstructured":"Stockinger, S. et al. Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes. PLoS Pathog. 5, e1000355 (2009).","journal-title":"PLoS Pathog."},{"key":"BFnri3787_CR164","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1084\/jem.20091746","volume":"207","author":"M Rayamajhi","year":"2010","unstructured":"Rayamajhi, M., Humann, J., Penheiter, K., Andreasen, K. & Lenz, L. L. Induction of IFN-\u03b1\/\u03b2 enables Listeria monocytogenes to suppress macrophage activation by IFN-\u03b3. J. Exp. Med. 207, 327\u2013337 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR165","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.4049\/jimmunol.1203510","volume":"191","author":"SJ Kearney","year":"2013","unstructured":"Kearney, S. J. et al. Type I IFNs downregulate myeloid cell IFN-\u03b3 receptor by inducing recruitment of an early growth response 3\/NGFI-A binding protein 1 complex that silences ifngr1 transcription. J. Immunol. 191, 3384\u20133392 (2013).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR166","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1089\/jir.2005.25.694","volume":"25","author":"C Manca","year":"2005","unstructured":"Manca, C. et al. Hypervirulent M. tuberculosis W\/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon Cytokine Res. 25, 694\u2013701 (2005).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFnri3787_CR167","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.179.1.522","volume":"179","author":"D Ordway","year":"2007","unstructured":"Ordway, D. et al. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. J. Immunol. 179, 522\u2013531 (2007).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR168","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.4049\/jimmunol.178.5.3143","volume":"178","author":"SA Stanley","year":"2007","unstructured":"Stanley, S. A., Johndrow, J. E., Manzanillo, P. & Cox, J. S. The type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J. Immunol. 178, 3143\u20133152 (2007).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR169","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1073\/pnas.091096998","volume":"98","author":"C Manca","year":"2001","unstructured":"Manca, C. et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-\u03b1\/\u03b2. Proc. Natl Acad. Sci. USA 98, 5752\u20135757 (2001). This study was the first demonstration of type I IFNs contributing to the exacerbation of tuberculosis in experimental mouse models.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3787_CR170","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1128\/IAI.68.12.6879-6882.2000","volume":"68","author":"AM Cooper","year":"2000","unstructured":"Cooper, A. M., Pearl, J. E., Brooks, J. V., Ehlers, S. & Orme, I. M. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect. Immun. 68, 6879\u20136882 (2000).","journal-title":"Infect. Immun."},{"key":"BFnri3787_CR171","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","volume":"466","author":"MP Berry","year":"2010","unstructured":"Berry, M. P. et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466, 973\u2013977 (2010). This study provided the first evidence that type I IFN-mediated signalling is associated with active tuberculosis in humans.","journal-title":"Nature"},{"key":"BFnri3787_CR172","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/jis499","volume":"207","author":"JM Cliff","year":"2013","unstructured":"Cliff, J. M. et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J. Infect. Dis. 207, 18\u201329 (2013).","journal-title":"J. Infect. Dis."},{"key":"BFnri3787_CR173","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/gene.2010.51","volume":"12","author":"J Maertzdorf","year":"2011","unstructured":"Maertzdorf, J. et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun. 12, 15\u201322 (2011).","journal-title":"Genes Immun."},{"key":"BFnri3787_CR174","doi-asserted-by":"crossref","first-page":"e45839","DOI":"10.1371\/journal.pone.0045839","volume":"7","author":"TH Ottenhoff","year":"2012","unstructured":"Ottenhoff, T. H. et al. Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS ONE 7, e45839 (2012).","journal-title":"PLoS ONE"},{"key":"BFnri3787_CR175","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1172\/JCI40817","volume":"120","author":"LR Antonelli","year":"2010","unstructured":"Antonelli, L. R. et al. Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte\/macrophage population. J. Clin. Invest. 120, 1674\u20131682 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnri3787_CR176","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","volume":"35","author":"KD Mayer-Barber","year":"2011","unstructured":"Mayer-Barber, K. D. et al. Innate and adaptive interferons suppress IL-1\u03b1 and IL-1\u03b2 production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35, 1023\u20131034 (2011).","journal-title":"Immunity"},{"key":"BFnri3787_CR177","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4049\/jimmunol.1300146","volume":"191","author":"FW McNab","year":"2013","unstructured":"McNab, F. W. et al. TPL-2-ERK1\/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production. J. Immunol. 191, 1732\u20131743 (2013).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR178","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/infdis\/jit424","volume":"209","author":"PS Redford","year":"2014","unstructured":"Redford, P. S. et al. Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J. Infect. Dis. 209, 270\u2013274 (2014).","journal-title":"J. Infect. Dis."},{"key":"BFnri3787_CR179","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.0904189","volume":"184","author":"KD Mayer-Barber","year":"2010","unstructured":"Mayer-Barber, K. D. et al. Caspase-1 independent IL-1\u03b2 production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 184, 3326\u20133330 (2010).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR180","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cyto.2012.12.005","volume":"61","author":"RA de Paus","year":"2013","unstructured":"de Paus, R. A. et al. Inhibition of the type I immune responses of human monocytes by IFN-\u03b1 and IFN-\u03b2. Cytokine 61, 645\u2013655 (2013).","journal-title":"Cytokine"},{"key":"BFnri3787_CR181","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.4049\/jimmunol.1100926","volume":"187","author":"A Novikov","year":"2011","unstructured":"Novikov, A. et al. Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1\u03b2 production in human macrophages. J. Immunol. 187, 2540\u20132547 (2011).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR182","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.4049\/jimmunol.1401088","volume":"193","author":"FW McNab","year":"2014","unstructured":"McNab, F. W. et al. Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-\u03b3 for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages. J. Immunol. 193, 3600\u20133612 (2014). This key study demonstrates the mechanisms underlying the adverse effects of type I IFNs in tuberculosis, including blocking of the protective type II IFN action, as well as blocking of IL-12, IL-1 and TNF production, in part through IL-10 induction.","journal-title":"J. Immunol."},{"key":"BFnri3787_CR183","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","volume":"34","author":"G Guarda","year":"2011","unstructured":"Guarda, G. et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34, 213\u2013223 (2011). This was the first study to show inhibition of the inflammasome by type I IFNs.","journal-title":"Immunity"},{"key":"BFnri3787_CR184","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature13489","volume":"511","author":"KD Mayer-Barber","year":"2014","unstructured":"Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99\u2013103 (2014). This seminal study shows the counter-regulatory function of IL-1 and type I IFNs in controlling the outcome of  M. tuberculosis  infection via eicosanoids.","journal-title":"Nature"},{"key":"BFnri3787_CR185","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.4049\/jimmunol.180.4.2125","volume":"180","author":"XJ Xu","year":"2008","unstructured":"Xu, X. J., Reichner, J. S., Mastrofrancesco, B., Henry, W. L. Jr & Albina, J. E. Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-\u03b2 production. J. Immunol. 180, 2125\u20132131 (2008). This study provided the first demonstration that prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN\u03b2 production.","journal-title":"J. Immunol."},{"key":"BFnri3787_CR186","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.immuni.2014.02.013","volume":"40","author":"F Coulombe","year":"2014","unstructured":"Coulombe, F. et al. Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages. Immunity 40, 554\u2013568 (2014).","journal-title":"Immunity"},{"key":"BFnri3787_CR187","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.1233665","volume":"339","author":"RM Teles","year":"2013","unstructured":"Teles, R. M. et al. Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 339, 1448\u20131453 (2013). In this key study, a mechanism is reported for type I IFN-mediated blocking of the protective role of type II IFN in tuberculosis.","journal-title":"Science"},{"key":"BFnri3787_CR188","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.4049\/jimmunol.1200255","volume":"188","author":"L Desvignes","year":"2012","unstructured":"Desvignes, L., Wolf, A. J. & Ernst, J. D. Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. J. Immunol. 188, 6205\u20136215 (2012). This important study shows that type I IFNs contribute to protection against  M. tuberculosis  when type II IFN-mediated signalling is aberrant.","journal-title":"J. Immunol."},{"key":"BFnri3787_CR189","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.1224026","volume":"337","author":"D Bogunovic","year":"2012","unstructured":"Bogunovic, D. et al. Mycobacterial disease and impaired IFN-\u03b3 immunity in humans with inherited ISG15 deficiency. Science 337, 1684\u20131688 (2012).","journal-title":"Science"},{"key":"BFnri3787_CR190","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1128\/IAI.72.8.4385-4392.2004","volume":"72","author":"S Mariotti","year":"2004","unstructured":"Mariotti, S. et al. Mycobacterium tuberculosis diverts \u03b1 interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells. Infect. Immun. 72, 4385\u20134392 (2004).","journal-title":"Infect. Immun."},{"key":"BFnri3787_CR191","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ni.1859","volume":"11","author":"T Fernandes-Alnemri","year":"2010","unstructured":"Fernandes-Alnemri, T. et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nature Immunol. 11, 385\u2013393 (2010).","journal-title":"Nature Immunol."},{"key":"BFnri3787_CR192","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1084\/jem.20062665","volume":"204","author":"T Henry","year":"2007","unstructured":"Henry, T., Brotcke, A., Weiss, D. S., Thompson, L. J. & Monack, D. M. Type I interferon signaling is required for activation of the inflammasome during Francisella infection. J. Exp. Med. 204, 987\u2013994 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR193","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.4049\/jimmunol.0902065","volume":"184","author":"T Henry","year":"2010","unstructured":"Henry, T. et al. Type I IFN signaling constrains IL-17A\/F secretion by \u03b3\u03b4 T cells during bacterial infections. J. Immunol. 184, 3755\u20133767 (2010).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR194","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.4049\/jimmunol.1301331","volume":"191","author":"S Shah","year":"2013","unstructured":"Shah, S. et al. Mycobacterium tuberculosis but not nonvirulent mycobacteria inhibits IFN-\u03b2 and AIM2 inflammasome-dependent IL-1\u03b2 production via its ESX-1 secretion system. J. Immunol. 191, 3514\u20133518 (2013).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR195","doi-asserted-by":"crossref","first-page":"e1000722","DOI":"10.1371\/journal.ppat.1000722","volume":"6","author":"K Al Moussawi","year":"2010","unstructured":"Al Moussawi, K. et al. Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei. PLoS Pathog. 6, e1000722 (2010).","journal-title":"PLoS Pathog."},{"key":"BFnri3787_CR196","doi-asserted-by":"crossref","first-page":"e23135","DOI":"10.1371\/journal.pone.0023135","volume":"6","author":"LA de Almeida","year":"2011","unstructured":"de Almeida, L. A. et al. MyD88 and STING signaling pathways are required for IRF3-mediated IFN-\u03b2 induction in response to Brucella abortus infection. PLoS ONE 6, e23135 (2011).","journal-title":"PLoS ONE"},{"key":"BFnri3787_CR197","doi-asserted-by":"crossref","first-page":"e1002817","DOI":"10.1371\/journal.ppat.1002817","volume":"8","author":"AA Patel","year":"2012","unstructured":"Patel, A. A., Lee-Lewis, H., Hughes-Hanks, J., Lewis, C. A. & Anderson, D. M. Opposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plague. PLoS Pathog. 8, e1002817 (2012).","journal-title":"PLoS Pathog."},{"key":"BFnri3787_CR198","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/ni.2397","volume":"13","author":"N Robinson","year":"2012","unstructured":"Robinson, N. et al. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nature Immunol. 13, 954\u2013962 (2012).","journal-title":"Nature Immunol."},{"key":"BFnri3787_CR199","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cell.2012.07.007","volume":"150","author":"VA Rathinam","year":"2012","unstructured":"Rathinam, V. A. et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by Gram-negative bacteria. Cell 150, 606\u2013619 (2012).","journal-title":"Cell"},{"key":"BFnri3787_CR200","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nature11419","volume":"490","author":"P Broz","year":"2012","unstructured":"Broz, P. et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490, 288\u2013291 (2012).","journal-title":"Nature"},{"key":"BFnri3787_CR201","first-page":"1931","volume":"119","author":"FJ Martin","year":"2009","unstructured":"Martin, F. J. et al. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J. Clin. Invest. 119, 1931\u20131939 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnri3787_CR202","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1074-7613(00)80460-4","volume":"8","author":"A Diefenbach","year":"1998","unstructured":"Diefenbach, A. et al. Type 1 interferon (IFN\u03b1\/\u03b2) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8, 77\u201387 (1998).","journal-title":"Immunity"},{"key":"BFnri3787_CR203","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/1521-4141(2000)30:8<2257::AID-IMMU2257>3.0.CO;2-U","volume":"30","author":"J Mattner","year":"2000","unstructured":"Mattner, J. et al. Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major. Eur. J. Immunol. 30, 2257\u20132267 (2000).","journal-title":"Eur. J. Immunol."},{"key":"BFnri3787_CR204","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.4049\/jimmunol.172.12.7574","volume":"172","author":"J Mattner","year":"2004","unstructured":"Mattner, J. et al. Protection against progressive leishmaniasis by IFN-\u03b2. J. Immunol. 172, 7574\u20137582 (2004).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR205","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.4049\/jimmunol.0802860","volume":"182","author":"R Khouri","year":"2009","unstructured":"Khouri, R. et al. IFN-\u03b2 impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis. J. Immunol. 182, 2525\u20132531 (2009).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR206","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.4049\/jimmunol.0903273","volume":"184","author":"L Xin","year":"2010","unstructured":"Xin, L. et al. Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites. J. Immunol. 184, 7047\u20137056 (2010).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR207","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/eji.201141539","volume":"41","author":"A Haque","year":"2011","unstructured":"Haque, A. et al. Type I interferons suppress CD4+ T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur. J. Immunol. 41, 2688\u20132698 (2011).","journal-title":"Eur. J. Immunol."},{"key":"BFnri3787_CR208","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1182\/blood.V97.12.3966","volume":"97","author":"AM Vigario","year":"2001","unstructured":"Vigario, A. M. et al. Inhibition of Plasmodium yoelii blood-stage malaria by interferon \u03b1 through the inhibition of the production of its target cell, the reticulocyte. Blood 97, 3966\u20133971 (2001).","journal-title":"Blood"},{"key":"BFnri3787_CR209","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.4049\/jimmunol.178.10.6416","volume":"178","author":"AM Vigario","year":"2007","unstructured":"Vigario, A. M. et al. Recombinant human IFN-\u03b1 inhibits cerebral malaria and reduces parasite burden in mice. J. Immunol. 178, 6416\u20136425 (2007).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR210","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ijpara.2009.11.005","volume":"40","author":"C Voisine","year":"2010","unstructured":"Voisine, C., Mastelic, B., Sponaas, A. M. & Langhorne, J. Classical CD11c+ dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria. Int. J. Parasitol. 40, 711\u2013719 (2010).","journal-title":"Int. J. Parasitol."},{"key":"BFnri3787_CR211","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm.3424","volume":"20","author":"P Liehl","year":"2014","unstructured":"Liehl, P. et al. Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection. Nature Med. 20, 47\u201353 (2014).","journal-title":"Nature Med."},{"key":"BFnri3787_CR212","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.4049\/jimmunol.177.5.3193","volume":"177","author":"VM Costa","year":"2006","unstructured":"Costa, V. M. et al. Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection. J. Immunol. 177, 3193\u20133200 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR213","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.4049\/jimmunol.177.10.7059","volume":"177","author":"R Koga","year":"2006","unstructured":"Koga, R. et al. TLR-dependent induction of IFN-\u03b2 mediates host defense against Trypanosoma cruzi. J. Immunol. 177, 7059\u20137066 (2006).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR214","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.181.7.4908","volume":"181","author":"R Lopez","year":"2008","unstructured":"Lopez, R., Demick, K. P., Mansfield, J. M. & Paulnock, D. M. Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes. J. Immunol. 181, 4908\u20134917 (2008).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR215","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1128\/IAI.01176-10","volume":"79","author":"AD Chessler","year":"2011","unstructured":"Chessler, A. D., Caradonna, K. L., Da'dara, A. & Burleigh, B. A. Type I interferons increase host susceptibility to Trypanosoma cruzi infection. Infect. Immun. 79, 2112\u20132119 (2011).","journal-title":"Infect. Immun."},{"key":"BFnri3787_CR216","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2249.2003.02294.x","volume":"134","author":"C Une","year":"2003","unstructured":"Une, C., Andersson, J. & Orn, A. Role of IFN-\u03b1\/\u03b2 and IL-12 in the activation of natural killer cells and interferon-\u03b3 production during experimental infection with Trypanosoma cruzi. Clin. Exp. Immunol. 134, 195\u2013201 (2003).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnri3787_CR217","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.181.1.566","volume":"181","author":"C Biondo","year":"2008","unstructured":"Biondo, C. et al. IFN-\u03b1\/\u03b2 signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental cryptococcosis. J. Immunol. 181, 566\u2013573 (2008).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR218","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/eji.201141490","volume":"41","author":"C Biondo","year":"2011","unstructured":"Biondo, C. et al. Recognition of yeast nucleic acids triggers a host-protective type I interferon response. Eur. J. Immunol. 41, 1969\u20131979 (2011).","journal-title":"Eur. J. Immunol."},{"key":"BFnri3787_CR219","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.immuni.2013.05.010","volume":"38","author":"C del Fresno","year":"2013","unstructured":"del Fresno, C. et al. Interferon-\u03b2 production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity 38, 1176\u20131186 (2013).","journal-title":"Immunity"},{"key":"BFnri3787_CR220","doi-asserted-by":"crossref","first-page":"e1002811","DOI":"10.1371\/journal.ppat.1002811","volume":"8","author":"O Majer","year":"2012","unstructured":"Majer, O. et al. Type I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infections. PLoS Pathog. 8, e1002811 (2012).","journal-title":"PLoS Pathog."},{"key":"BFnri3787_CR221","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.4049\/jimmunol.1002599","volume":"186","author":"C Bourgeois","year":"2011","unstructured":"Bourgeois, C. et al. Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-\u03b2 signaling. J. Immunol. 186, 3104\u20133112 (2011).","journal-title":"J. Immunol."},{"key":"BFnri3787_CR222","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/IAI.00204-10","volume":"78","author":"DO Inglis","year":"2010","unstructured":"Inglis, D. O., Berkes, C. A., Hocking Murray, D. R. & Sil, A. Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages. Infect. Immun. 78, 3871\u20133882 (2010).","journal-title":"Infect. Immun."},{"key":"BFnri3787_CR223","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","volume":"208","author":"L Liu","year":"2011","unstructured":"Liu, L. et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208, 1635\u20131648 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnri3787_CR224","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1100102","volume":"365","author":"FL van de Veerdonk","year":"2011","unstructured":"van de Veerdonk, F. L. et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 365, 54\u201361 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnri3787_CR225","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","volume":"198","author":"DM Morens","year":"2008","unstructured":"Morens, D. M., Taubenberger, J. K. & Fauci, A. S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962\u2013970 (2008).","journal-title":"J. Infect. Dis."},{"key":"BFnri3787_CR226","doi-asserted-by":"crossref","first-page":"12304","DOI":"10.1128\/JVI.01269-12","volume":"86","author":"W Li","year":"2012","unstructured":"Li, W., Moltedo, B. & Moran, T. M. Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of \u03b3\u03b4 T cells. J. Virol. 86, 12304\u201312312 (2012).","journal-title":"J. Virol."},{"key":"BFnri3787_CR227","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1172\/JCI57762","volume":"121","author":"S Nakamura","year":"2011","unstructured":"Nakamura, S., Davis, K. M. & Weiser, J. N. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J. Clin. Invest. 121, 3657\u20133665 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnri3787_CR228","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1172\/JCI35412","volume":"119","author":"A Shahangian","year":"2009","unstructured":"Shahangian, A. et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J. Clin. Invest. 119, 1910\u20131920 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnri3787_CR229","doi-asserted-by":"crossref","first-page":"e41879","DOI":"10.1371\/journal.pone.0041879","volume":"7","author":"X Tian","year":"2012","unstructured":"Tian, X. et al. Poly I:C enhances susceptibility to secondary pulmonary infections by Gram-positive bacteria. PLoS ONE 7, e41879 (2012).","journal-title":"PLoS ONE"},{"key":"BFnri3787_CR230","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.0607325103","volume":"103","author":"AA Navarini","year":"2006","unstructured":"Navarini, A. A. et al. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc. Natl Acad. Sci. USA 103, 15535\u201315539 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri3787_CR231","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.chom.2011.05.006","volume":"9","author":"YG Kim","year":"2011","unstructured":"Kim, Y. G. et al. Viral infection augments Nod1\/2 signaling to potentiate lethality associated with secondary bacterial infections. Cell Host Microbe 9, 496\u2013507 (2011).","journal-title":"Cell Host Microbe"},{"key":"BFnri3787_CR232","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid, Y. & Hand, T. W. Role of the microbiota in immunity and inflammation. Cell 157, 121\u2013141 (2014).","journal-title":"Cell"},{"key":"BFnri3787_CR233","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.immuni.2012.05.020","volume":"37","author":"SC Ganal","year":"2012","unstructured":"Ganal, S. C. et al. Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 37, 171\u2013186 (2012).","journal-title":"Immunity"},{"key":"BFnri3787_CR234","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.immuni.2012.04.011","volume":"37","author":"MC Abt","year":"2012","unstructured":"Abt, M. C. et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 37, 158\u2013170 (2012).","journal-title":"Immunity"},{"key":"BFnri3787_CR235","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/gutjnl-2013-305863","volume":"63","author":"M Tschurtschenthaler","year":"2014","unstructured":"Tschurtschenthaler, M. et al. Type I interferon signalling in the intestinal epithelium affects Paneth cells, microbial ecology and epithelial regeneration. Gut 63, 1921\u20131931 (2014).","journal-title":"Gut"},{"key":"BFnri3787_CR236","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.immuni.2013.02.024","volume":"38","author":"T Kawashima","year":"2013","unstructured":"Kawashima, T. et al. Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-\u03b2. Immunity 38, 1187\u20131197 (2013). This study shows that the microbiota contributes to the initial production of protective type I IFNs. References 235 and 236 collectively demonstrate a novel interplay between the microbiota, type I IFNs and consequent protection against pathogens.","journal-title":"Immunity"},{"key":"BFnri3787_CR237","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.immuni.2012.01.011","volume":"36","author":"DJ Gough","year":"2012","unstructured":"Gough, D. J., Messina, N. L., Clarke, C. J., Johnstone, R. W. & Levy, D. E. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36, 166\u2013174 (2012).","journal-title":"Immunity"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nri3787.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri3787","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri3787.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:28:43Z","timestamp":1733941723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nri3787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,23]]},"references-count":237,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFnri3787"],"URL":"https:\/\/doi.org\/10.1038\/nri3787","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,23]]},"assertion":[{"value":"23 January 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}